Cargando…

Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database

Mature B-cell non-Hodgkin lymphoma (B-NHL) constitutes a collection of relatively rare pediatric malignancies. In order to utilize administrative data to perform large-scale epidemiologic studies within this population, a two-step process was used to assemble a 12-year cohort of B-NHL patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Citrin, Rebecca, Horowitz, Joseph P., Reilly, Anne F., Li, Yimei, Huang, Yuan-Shung, Getz, Kelly D., Seif, Alix E., Fisher, Brian T., Aplenc, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653357/ https://www.ncbi.nlm.nih.gov/pubmed/29059235 http://dx.doi.org/10.1371/journal.pone.0186960

Ejemplares similares

Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia
por: Getz, Kelly D., et al.
Publicado: (2018)

A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia
por: Getz, Kelly D, et al.
Publicado: (2015)

Merging Children’s Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children’s Oncology Group
por: Li, Yimei, et al.
Publicado: (2015)

Early discharge as a mediator of greater ICU‐level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report
por: Getz, Kelly D., et al.
Publicado: (2016)

Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States
por: DiNofia, Amanda M., et al.
Publicado: (2016)

Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma
por: Agrusa, Jennifer E., et al.
Publicado: (2020)

Non-Hodgkin lymphoma after pediatric kidney transplantation
por: Grenda, Ryszard
Publicado: (2021)

P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL
por: Flerlage, Jamie E., et al.
Publicado: (2022)

Ultrasound presentation of abdominal non-Hodgkin lymphomas in pediatric patients
por: Brodzisz, Agnieszka, et al.
Publicado: (2013)

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
por: Derebas, Justyna, et al.
Publicado: (2022)

CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma
por: Ostojska, Magdalena, et al.
Publicado: (2023)

Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
por: Sorge, Caryn E., et al.
Publicado: (2016)

Tuberculosis Coexistence in Pediatric Hodgkin’s Lymphoma: A Tropical Country Experience
por: Padma, Maneya, et al.
Publicado: (2020)

Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
por: De Re, Valli, et al.
Publicado: (2022)

Non-Hodgkin’s Lymphoma Presenting as Esophageal Stenosis in a Pediatric Patient
por: Lee, Jeffrey, et al.
Publicado: (2022)

Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

Abdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary?
por: Farruggia, Piero, et al.
Publicado: (2016)

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma
por: De Re, Valli, et al.
Publicado: (2017)

Pediatric Hodgkin lymphoma– biomarkers, drugs, and clinical trials for translational science and medicine
por: Nagpal, Poonam, et al.
Publicado: (2016)

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
por: Forlenza, Christopher J., et al.
Publicado: (2021)

Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology Group
por: Vujkovic, Marijana, et al.
Publicado: (2016)

Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia
por: Getz, Kelly D., et al.
Publicado: (2021)

Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH
por: Zijtregtop, Eline A. M., et al.
Publicado: (2023)

Thyroid Functions in Long-Term Survivors of Pediatric Hodgkin’s Lymphoma Treated with Chemotherapy and Radiotherapy
por: Demirkaya, Metin, et al.
Publicado: (2011)

Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2016)

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Clinical Characteristics and Treatment Outcomes of Pediatric Patients with Non-Hodgkin Lymphoma in East Asia
por: Suh, Jin Kyung, et al.
Publicado: (2020)

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2020)

Ovarian Non-Hodgkin Lymphoma Revealed by Bone Metastasis: A Rare Pediatric Case
por: Elbaz, M., et al.
Publicado: (2021)

Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2020)

Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2022)

Are Semiquantitative Methods Superior to Deauville Scoring in the Monitoring Therapy Response for Pediatric Hodgkin Lymphoma?
por: Ibrahim, Firuz, et al.
Publicado: (2023)

Digital pathology in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: correlation with treatment response
por: Sereda, Sergej, et al.
Publicado: (2023)

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
por: Forlenza, Christopher J., et al.
Publicado: (2023)

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
por: Weisman, Amy J., et al.
Publicado: (2020)

Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232
por: DiNofia, Amanda M., et al.
Publicado: (2017)

Pediatric pulmonary hodgkin lymphoma: Analysis of 10 years data from a single center
por: Urasinski, T, et al.
Publicado: (2010)

Effect of Akimbo versus Raised Arm Positioning on Breast and Cardiopulmonary Dosimetry in Pediatric Hodgkin Lymphoma
por: Denniston, Kyle A., et al.
Publicado: (2016)

When is surgical resection alone appropriate treatment for pediatric nodular lymphocyte-predominant Hodgkin lymphoma?
por: Bessen, Sarah Y, et al.
Publicado: (2021)

Minimal Disease Monitoring in Pediatric Non-Hodgkin’s Lymphoma: Current Clinical Application and Future Challenges
por: Mussolin, Lara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_306u1vqav84gbil7tqr5gab6va